News & Articles
How to unlock the complexity of tumor microenvironments
Learn how researchers used the Orion™ platform from RareCyte to generate spatial insights into tumor microenvironments
Collaboration drives antimicrobial stewardship improvements
Understand the importance of fostering cross-department collaboration for an optimal antimicrobial stewardship program
Auto dilution system redefines sustainability in labs
Find out how Agilent Technologies' Advanced Dilution System 2 (ADS 2) enhances lab efficiency and accuracy, while significantly reducing environmental impacts by minimizing plastic waste and argon usage
ddPCR to innovate replication-competent virus testing
Could ddPCR offer a rapid and reliable alternative to qPCR for replication-competent virus testing in gene therapy development?
Unlock the potential of liquid biopsies to revolutionize cancer detection
Nucleic acids in blood can provide valuable information about cancer, but how can we stabilize them prior to analysis?
How Merck aids lateral flow test development
From the manufacture and supply of raw materials to risk mitigation and assay development capabilities, learn how Merck is helping IVD developers bring new devices to market
Vote for the Best New Clinical Diagnostic Products in the Scientists’ Choice Awards
For the chance to win a $500 Amazon Gift Card (or equivalent currency) cast your vote for the new products which have made the most difference to clinical diagnostics
Accelerating Science: How to protect the environment with clean science
Visit our new Accelerating Science Feature to explore the remarkable achievements in the fields of PFAS, battery testing, and beyond
Clinical webinar of the month: Scopio digital morphology
This month’s webinar explores digitization and context in full-field morphological hematology
Masterclass: Optimizing lead management to grow funnel conversions
Available on Demand
Automation in liquid biopsy transforms cancer care
New automations in liquid biopsy research hold great promise for bringing us even closer to fully realizing its clinical utility in monitoring cancer from diagnosis through to remission
Deep learning tool boosts drug discovery
Learn how CDD’s AI search tool offers a rapid and secure means to discover and optimize promising drug candidates
SelectScience and ELRIG partner to pioneer digital event experience
On July 3, SelectScience and ELRIG will be hosting an online event showcasing advances in cell-based screening in drug discovery to extend high-quality content to the global audience
High-sensitivity troponin at the point of care
Professor of Emergency Medicine at the University of Manchester highlights the promise of point-of-care high-sensitivity troponin assays in the emergency department
Point-of-care ecosystems are revolutionizing healthcare
Explore the modern point-of-care ecosystem and its impact on healthcare delivery
Clinical webinar explores testing for Graves’ Disease
Learn about clinical aspects of Graves’ Disease and the use of TSH immunoglobulin assay for diagnosis and monitoring
ASMS 2024 Annual Conference highlights
The role of soil in regenerative agriculture
This guest editorial explores how regenerative agriculture can solve current farming challenges, and how soil health may be the answer under our feet
Optimizing battery testing performance
Learn about the different types of battery testing and explore additional considerations for optimizing performance
Digital transformation in healthcare challenges clinical labs
An introduction to the challenges and considerations for clinical labs embarking on digital transformation in healthcare
Automated cell counting increases efficiency of neurology research at Yale School of Medicine
Learn how the latest automated cell counting technology is enhancing autoimmune disease research at Yale School of Medicine’s Hafler Lab
Analytical Science Scientists’ Choice Awards winners announced
Agilent Technologies, Merck, ZEISS, and Waters among those recognized
Patient-derived organoids open doors to personalized medicine
Dr. Kangxin He at Zhejiang University has developed a high-throughput drug screening platform using patient-derived organoids to identify the best treatment for individual patients